Nurix Therapeutics NRIX
NASDAQ NRIX
$23.67 +0.00 (+0.02%)
At close: Sep 29, 2026 · 4:00 PM EDT

Nurix Therapeutics (NRIX) Non-Current Assets (2019 - 2026)

Updated

Nurix Therapeutics (NRIX) recorded Non-Current Assets of $79.06 million in fiscal Q2 2026 (quarter ended May 31, 2026), up 3.7% from $76.23 million a year earlier but down 3.3% from the prior quarter.

Analysis

Nurix Therapeutics (NRIX) Non-Current Assets (2019 - 2026) Analysis & Trends

At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics reported Non-Current Assets of $81.32 million, up 62.8% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
  • Across earlier fiscal years, Non-Current Assets came in at $49.96 million in FY2024 (-16.9%), $60.1 million in FY2023 (-38.9%), $98.31 million in FY2022 (-40.7%) and $165.65 million in FY2021 (+69.2%).
  • Quarterly Non-Current Assets has ranged from $40.25 million in fiscal Q3 2023 to $165.65 million in fiscal Q4 2021 over the past five years.
  • On a year-over-year basis, Non-Current Assets has increased for five consecutive quarters, with growth averaging 25.3% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 181.7% in fiscal Q3 2021, against a decline of 61.5% in fiscal Q3 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $81.74 million (Q1 2026), $81.32 million (Q4 2025) and $81.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Nurix Therapeutics 2.45 Bn 448.58 Mn - 79.06 Mn
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 79.06 Mn
Feb 28, 2026 81.74 Mn
Nov 30, 2025 81.32 Mn
Aug 31, 2025 81.87 Mn
May 31, 2025 76.23 Mn
Feb 28, 2025 51.34 Mn
Nov 30, 2024 49.96 Mn
Aug 31, 2024 57.56 Mn
May 31, 2024 60.81 Mn
Feb 29, 2024 61.71 Mn
Nov 30, 2023 60.10 Mn
Aug 31, 2023 40.25 Mn
May 31, 2023 60.61 Mn
Feb 28, 2023 81.83 Mn
Nov 30, 2022 98.31 Mn
Aug 31, 2022 104.47 Mn
May 31, 2022 87.52 Mn
Feb 28, 2022 157.24 Mn
Nov 30, 2021 165.65 Mn
Aug 31, 2021 134.63 Mn
API Access

Nurix Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=NRIX&period=max&api_key=YOUR_API_KEY